BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
41.515 EUR
-0.58 (-1.38%)
Taking everything into account, BAYN scores 3 out of 10 in our fundamental rating. BAYN was compared to 53 industry peers in the Pharmaceuticals industry. BAYN may be in some trouble as it scores bad on both profitability and health. BAYN has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
- BAYN had positive earnings in the past year.
- In the past year BAYN had a positive cash flow from operations.
- In multiple years BAYN reported negative net income over the last 5 years.
- In the past 5 years BAYN always reported a positive cash flow from operatings.
1.2 Ratios
- BAYN's Return On Assets of -0.19% is on the low side compared to the rest of the industry. BAYN is outperformed by 66.04% of its industry peers.
- BAYN's Return On Equity of -0.67% is on the low side compared to the rest of the industry. BAYN is outperformed by 66.04% of its industry peers.
- BAYN has a worse Return On Invested Capital (1.80%) than 66.04% of its industry peers.
- BAYN had an Average Return On Invested Capital over the past 3 years of 5.51%. This is significantly below the industry average of 14.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROIC | 1.8% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
1.3 Margins
- The Operating Margin of BAYN (4.20%) is worse than 64.15% of its industry peers.
- In the last couple of years the Operating Margin of BAYN has declined.
- With a Gross Margin value of 56.35%, BAYN is not doing good in the industry: 67.92% of the companies in the same industry are doing better.
- BAYN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BAYN is destroying value.
- BAYN has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, BAYN has about the same amount of shares outstanding.
- BAYN has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of 1.00, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
- BAYN has a worse Altman-Z score (1.00) than 69.81% of its industry peers.
- The Debt to FCF ratio of BAYN is 10.07, which is on the high side as it means it would take BAYN, 10.07 years of fcf income to pay off all of its debts.
- BAYN's Debt to FCF ratio of 10.07 is on the low side compared to the rest of the industry. BAYN is outperformed by 60.38% of its industry peers.
- BAYN has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of BAYN (1.11) is worse than 66.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 1 |
ROIC/WACC0.27
WACC6.66%
2.3 Liquidity
- BAYN has a Current Ratio of 1.14. This is a normal value and indicates that BAYN is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of BAYN (1.14) is worse than 62.26% of its industry peers.
- BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.71, BAYN is doing worse than 69.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
- BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
- Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
- Looking at the last year, BAYN shows a decrease in Revenue. The Revenue has decreased by -1.87% in the last year.
- BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
- The Earnings Per Share is expected to grow by 3.51% on average over the next years.
- BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.22% yearly.
EPS Next Y-5.16%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
EPS Next 5Y3.51%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 7.77, which indicates a rather cheap valuation of BAYN.
- Based on the Price/Earnings ratio, BAYN is valued cheaply inside the industry as 98.11% of the companies are valued more expensively.
- BAYN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.54.
- BAYN is valuated reasonably with a Price/Forward Earnings ratio of 8.53.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 92.45% of the companies listed in the same industry.
- BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.77 | ||
| Fwd PE | 8.53 |
4.2 Price Multiples
- 64.15% of the companies in the same industry are more expensive than BAYN, based on the Enterprise Value to EBITDA ratio.
- 90.57% of the companies in the same industry are more expensive than BAYN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.36 | ||
| EV/EBITDA | 11.78 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.28%, BAYN is not a good candidate for dividend investing.
- BAYN's Dividend Yield is slightly below the industry average, which is at 1.72.
- With a Dividend Yield of 0.28, BAYN pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.28% |
5.2 History
- The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-65.15%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
FRA:BAYN (1/16/2026, 5:36:15 PM)
41.515
-0.58 (-1.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners49.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap40.79B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts74.29
Price Target34.35 (-17.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.28% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)5.41%
PT rev (3m)18.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.41%
EPS NY rev (1m)0.49%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.77 | ||
| Fwd PE | 8.53 | ||
| P/S | 0.89 | ||
| P/FCF | 10.36 | ||
| P/OCF | 6.07 | ||
| P/B | 1.38 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.78 |
EPS(TTM)5.34
EY12.86%
EPS(NY)4.87
Fwd EY11.73%
FCF(TTM)4.01
FCFY9.65%
OCF(TTM)6.84
OCFY16.48%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROCE | 2.56% | ||
| ROIC | 1.8% | ||
| ROICexc | 2% | ||
| ROICexgc | 6.8% | ||
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM | 8.58% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 5.32 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 1.09 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 1 |
F-Score5
WACC6.66%
ROIC/WACC0.27
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.16%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
EPS Next 5Y3.51%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.28%
EBIT Next 3Y21.41%
EBIT Next 5Y12.99%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status of BAYER AG-REG (BAYN.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
How financially healthy is BAYER AG-REG?
The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.
How sustainable is the dividend of BAYER AG-REG (BAYN.DE) stock?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.